Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part...

Full description

Saved in:
Bibliographic Details
Published in:Journal of rheumatology 2019-07, Vol.46 (7), p.751-754
Main Authors: Papp, Kim A, Haraoui, Boulos, Kumar, Deepali, Marshall, John K, Bissonnette, Robert, Bitton, Alain, Bressler, Brian, Gooderham, Melinda, Ho, Vincent, Jamal, Shahin, Pope, Janet E, Steinhart, A Hillary, Vinh, Donald C, Wade, John
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c332t-250cb4bba82554933cd2c94c0bb57c1cb5cf03f9738413b27ed804b15f77f8d63
cites cdi_FETCH-LOGICAL-c332t-250cb4bba82554933cd2c94c0bb57c1cb5cf03f9738413b27ed804b15f77f8d63
container_end_page 754
container_issue 7
container_start_page 751
container_title Journal of rheumatology
container_volume 46
creator Papp, Kim A
Haraoui, Boulos
Kumar, Deepali
Marshall, John K
Bissonnette, Robert
Bitton, Alain
Bressler, Brian
Gooderham, Melinda
Ho, Vincent
Jamal, Shahin
Pope, Janet E
Steinhart, A Hillary
Vinh, Donald C
Wade, John
description The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases, and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive and immunomodulatory agents.
doi_str_mv 10.3899/jrheum.180784
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179497650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179497650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-250cb4bba82554933cd2c94c0bb57c1cb5cf03f9738413b27ed804b15f77f8d63</originalsourceid><addsrcrecordid>eNo9kEtLxDAYRYMoOj6WbiVLN9U8m8ad-BgFQcFR3JUk_epEpw-TRsd_7wxVVxcuh8vlIHRIyQkvtD59C3NIzQktiCrEBppQoXXGlGSbaEI4lRnN2csO2o3xjRCai7zYRjucKKK1kBO0fDbO-dYMvmvxNPkKFr6FiOsu4IdVC-0Q8Zcf5vi2aVILWQOVNwNU-NLHLlQQIp6Zd9--jkAXU98HiNF_Ap7NIZjeQzzDV0twaViXj6lpTPjeR1u1WUQ4-M099HR9Nbu4ye7up7cX53eZ45wNGZPEWWGtKZiUQnPuKua0cMRaqRx1Vrqa8ForXgjKLVNQFURYKmul6qLK-R46Hnf70H0kiEPZ-OhgsTAtdCmWjCottMolWaHZiLrQxRigLvvg119LSsq17HKUXY6yV_zR73SyKy3_9J9d_gP_FX7J</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179497650</pqid></control><display><type>article</type><title>Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary</title><source>Medical Journals</source><creator>Papp, Kim A ; Haraoui, Boulos ; Kumar, Deepali ; Marshall, John K ; Bissonnette, Robert ; Bitton, Alain ; Bressler, Brian ; Gooderham, Melinda ; Ho, Vincent ; Jamal, Shahin ; Pope, Janet E ; Steinhart, A Hillary ; Vinh, Donald C ; Wade, John</creator><creatorcontrib>Papp, Kim A ; Haraoui, Boulos ; Kumar, Deepali ; Marshall, John K ; Bissonnette, Robert ; Bitton, Alain ; Bressler, Brian ; Gooderham, Melinda ; Ho, Vincent ; Jamal, Shahin ; Pope, Janet E ; Steinhart, A Hillary ; Vinh, Donald C ; Wade, John</creatorcontrib><description>The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases, and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive and immunomodulatory agents.</description><identifier>ISSN: 0315-162X</identifier><identifier>EISSN: 1499-2752</identifier><identifier>DOI: 10.3899/jrheum.180784</identifier><identifier>PMID: 30709945</identifier><language>eng</language><publisher>Canada</publisher><ispartof>Journal of rheumatology, 2019-07, Vol.46 (7), p.751-754</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-250cb4bba82554933cd2c94c0bb57c1cb5cf03f9738413b27ed804b15f77f8d63</citedby><cites>FETCH-LOGICAL-c332t-250cb4bba82554933cd2c94c0bb57c1cb5cf03f9738413b27ed804b15f77f8d63</cites><orcidid>0000-0003-1347-7767</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30709945$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Papp, Kim A</creatorcontrib><creatorcontrib>Haraoui, Boulos</creatorcontrib><creatorcontrib>Kumar, Deepali</creatorcontrib><creatorcontrib>Marshall, John K</creatorcontrib><creatorcontrib>Bissonnette, Robert</creatorcontrib><creatorcontrib>Bitton, Alain</creatorcontrib><creatorcontrib>Bressler, Brian</creatorcontrib><creatorcontrib>Gooderham, Melinda</creatorcontrib><creatorcontrib>Ho, Vincent</creatorcontrib><creatorcontrib>Jamal, Shahin</creatorcontrib><creatorcontrib>Pope, Janet E</creatorcontrib><creatorcontrib>Steinhart, A Hillary</creatorcontrib><creatorcontrib>Vinh, Donald C</creatorcontrib><creatorcontrib>Wade, John</creatorcontrib><title>Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary</title><title>Journal of rheumatology</title><addtitle>J Rheumatol</addtitle><description>The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases, and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive and immunomodulatory agents.</description><issn>0315-162X</issn><issn>1499-2752</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9kEtLxDAYRYMoOj6WbiVLN9U8m8ad-BgFQcFR3JUk_epEpw-TRsd_7wxVVxcuh8vlIHRIyQkvtD59C3NIzQktiCrEBppQoXXGlGSbaEI4lRnN2csO2o3xjRCai7zYRjucKKK1kBO0fDbO-dYMvmvxNPkKFr6FiOsu4IdVC-0Q8Zcf5vi2aVILWQOVNwNU-NLHLlQQIp6Zd9--jkAXU98HiNF_Ap7NIZjeQzzDV0twaViXj6lpTPjeR1u1WUQ4-M099HR9Nbu4ye7up7cX53eZ45wNGZPEWWGtKZiUQnPuKua0cMRaqRx1Vrqa8ForXgjKLVNQFURYKmul6qLK-R46Hnf70H0kiEPZ-OhgsTAtdCmWjCottMolWaHZiLrQxRigLvvg119LSsq17HKUXY6yV_zR73SyKy3_9J9d_gP_FX7J</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Papp, Kim A</creator><creator>Haraoui, Boulos</creator><creator>Kumar, Deepali</creator><creator>Marshall, John K</creator><creator>Bissonnette, Robert</creator><creator>Bitton, Alain</creator><creator>Bressler, Brian</creator><creator>Gooderham, Melinda</creator><creator>Ho, Vincent</creator><creator>Jamal, Shahin</creator><creator>Pope, Janet E</creator><creator>Steinhart, A Hillary</creator><creator>Vinh, Donald C</creator><creator>Wade, John</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1347-7767</orcidid></search><sort><creationdate>20190701</creationdate><title>Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary</title><author>Papp, Kim A ; Haraoui, Boulos ; Kumar, Deepali ; Marshall, John K ; Bissonnette, Robert ; Bitton, Alain ; Bressler, Brian ; Gooderham, Melinda ; Ho, Vincent ; Jamal, Shahin ; Pope, Janet E ; Steinhart, A Hillary ; Vinh, Donald C ; Wade, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-250cb4bba82554933cd2c94c0bb57c1cb5cf03f9738413b27ed804b15f77f8d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Papp, Kim A</creatorcontrib><creatorcontrib>Haraoui, Boulos</creatorcontrib><creatorcontrib>Kumar, Deepali</creatorcontrib><creatorcontrib>Marshall, John K</creatorcontrib><creatorcontrib>Bissonnette, Robert</creatorcontrib><creatorcontrib>Bitton, Alain</creatorcontrib><creatorcontrib>Bressler, Brian</creatorcontrib><creatorcontrib>Gooderham, Melinda</creatorcontrib><creatorcontrib>Ho, Vincent</creatorcontrib><creatorcontrib>Jamal, Shahin</creatorcontrib><creatorcontrib>Pope, Janet E</creatorcontrib><creatorcontrib>Steinhart, A Hillary</creatorcontrib><creatorcontrib>Vinh, Donald C</creatorcontrib><creatorcontrib>Wade, John</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Papp, Kim A</au><au>Haraoui, Boulos</au><au>Kumar, Deepali</au><au>Marshall, John K</au><au>Bissonnette, Robert</au><au>Bitton, Alain</au><au>Bressler, Brian</au><au>Gooderham, Melinda</au><au>Ho, Vincent</au><au>Jamal, Shahin</au><au>Pope, Janet E</au><au>Steinhart, A Hillary</au><au>Vinh, Donald C</au><au>Wade, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary</atitle><jtitle>Journal of rheumatology</jtitle><addtitle>J Rheumatol</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>46</volume><issue>7</issue><spage>751</spage><epage>754</epage><pages>751-754</pages><issn>0315-162X</issn><eissn>1499-2752</eissn><abstract>The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases, and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive and immunomodulatory agents.</abstract><cop>Canada</cop><pmid>30709945</pmid><doi>10.3899/jrheum.180784</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-1347-7767</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0315-162X
ispartof Journal of rheumatology, 2019-07, Vol.46 (7), p.751-754
issn 0315-162X
1499-2752
language eng
recordid cdi_proquest_miscellaneous_2179497650
source Medical Journals
title Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A27%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccination%20Guidelines%20for%20Patients%20with%20Immune-mediated%20Disorders%20Taking%20Immunosuppressive%20Therapies:%20Executive%20Summary&rft.jtitle=Journal%20of%20rheumatology&rft.au=Papp,%20Kim%20A&rft.date=2019-07-01&rft.volume=46&rft.issue=7&rft.spage=751&rft.epage=754&rft.pages=751-754&rft.issn=0315-162X&rft.eissn=1499-2752&rft_id=info:doi/10.3899/jrheum.180784&rft_dat=%3Cproquest_cross%3E2179497650%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c332t-250cb4bba82554933cd2c94c0bb57c1cb5cf03f9738413b27ed804b15f77f8d63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2179497650&rft_id=info:pmid/30709945&rfr_iscdi=true